Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shock waves may zap headache pain – new study tests best dose

NCT ID NCT06879418

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether low or medium dose shock wave therapy can ease cervicogenic headaches (headaches that start from the neck). 135 people with neck pain and trigger points received either low dose, medium dose, or fake shock waves, plus exercises. Researchers measured headache disability and muscle activity before and after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
radial extracorporeal shock wave therapy
What this could lead to
If it works, this could provide a non-drug option to ease headache and neck pain from trigger points.
What could go wrong
This is a small, completed trial with no phase designation. Results may not apply to all headache types, and benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

135 people

The number who actually took part.

Started

Mar 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Symptoms of mechanical neck pain lasting for more than three months * Skeletal muscle with a palpable taut band * Hypersensitive point inside the taut band with the ability to reproduce referred pain when the sensitive spot is palpated, * Joint soreness in at least one of the upper cervical spine's joints (c1-c3) * Unilateral discomfort that originates in the neck and radiates to the frontotemporal area * Pain that is made worse by moving the neck * Headaches that occur at least once a week for a duration longer than three months. Exclusion Criteria: * Other primary headaches (i.e., migraine, tension-type headache) * Bilateral headaches, * Other defined cervical problem such as fracture, dislocation, skin disease, illness that is inflammatory, neural illness, vertebrobasilar insufficiency, a birth defect, tumor, or infection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervicogenic headache are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Post-Traumatic Headache

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Modern University for Technology and Information

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.